These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31041386)

  • 1. A Chemical Genetic Method for Monitoring Genome-Wide Dynamics of
    Liu TW; Myschyshyn M; Sinclair DA; Vocadlo DJ
    ACS Cent Sci; 2019 Apr; 5(4):663-670. PubMed ID: 31041386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chemical method for genome- and proteome-wide enrichment and O-GlcNAcylation profiling of chromatin-associated proteins.
    Huo B; Liu Y; Li L; Qin W
    Talanta; 2022 May; 241():123167. PubMed ID: 35091346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide chemical mapping of O-GlcNAcylated proteins in Drosophila melanogaster.
    Liu TW; Myschyshyn M; Sinclair DA; Cecioni S; Beja K; Honda BM; Morin RD; Vocadlo DJ
    Nat Chem Biol; 2017 Feb; 13(2):161-167. PubMed ID: 27918560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAcase Expression is Sensitive to Changes in O-GlcNAc Homeostasis.
    Zhang Z; Tan EP; VandenHull NJ; Peterson KR; Slawson C
    Front Endocrinol (Lausanne); 2014; 5():206. PubMed ID: 25520704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic profiling and genome-wide mapping of O-GlcNAc chromatin-associated proteins reveal an O-GlcNAc-regulated genotoxic stress response.
    Liu Y; Chen Q; Zhang N; Zhang K; Dou T; Cao Y; Liu Y; Li K; Hao X; Xie X; Li W; Ren Y; Zhang J
    Nat Commun; 2020 Nov; 11(1):5898. PubMed ID: 33214551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast cells as an assay system for in vivo O-GlcNAc modification.
    Nakanishi H; Li F; Han B; Arai S; Gao XD
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.
    Forsythe ME; Love DC; Lazarus BD; Kim EJ; Prinz WA; Ashwell G; Krause MW; Hanover JA
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11952-7. PubMed ID: 16882729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-GlcNAc: A Sweetheart of the Cell Cycle and DNA Damage Response.
    Liu C; Li J
    Front Endocrinol (Lausanne); 2018; 9():415. PubMed ID: 30105004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct One-Step Fluorescent Labeling of O-GlcNAc-Modified Proteins in Live Cells Using Metabolic Intermediates.
    Tan HY; Eskandari R; Shen D; Zhu Y; Liu TW; Willems LI; Alteen MG; Madden Z; Vocadlo DJ
    J Am Chem Soc; 2018 Nov; 140(45):15300-15308. PubMed ID: 30296064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.
    Akan I; Olivier-Van Stichelen S; Bond MR; Hanover JA
    J Neurochem; 2018 Jan; 144(1):7-34. PubMed ID: 29049853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of transcription factor function by O-GlcNAc modification.
    Ozcan S; Andrali SS; Cantrell JE
    Biochim Biophys Acta; 2010; 1799(5-6):353-64. PubMed ID: 20202486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
    Yuzwa SA; Vocadlo DJ
    Chem Soc Rev; 2014 Oct; 43(19):6839-58. PubMed ID: 24759912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An OGA-Resistant Probe Allows Specific Visualization and Accurate Identification of O-GlcNAc-Modified Proteins in Cells.
    Li J; Wang J; Wen L; Zhu H; Li S; Huang K; Jiang K; Li X; Ma C; Qu J; Parameswaran A; Song J; Zhao W; Wang PG
    ACS Chem Biol; 2016 Nov; 11(11):3002-3006. PubMed ID: 27622469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase.
    Macauley MS; Vocadlo DJ
    Biochim Biophys Acta; 2010 Feb; 1800(2):107-21. PubMed ID: 19664691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics.
    Olivier-Van Stichelen S; Hanover JA
    Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):339-45. PubMed ID: 26049631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAc and the control of gene expression.
    Comer FI; Hart GW
    Biochim Biophys Acta; 1999 Dec; 1473(1):161-71. PubMed ID: 10580136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
    Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
    PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a mutant OGA for detecting O-GlcNAc modified proteins.
    Chalkley RJ
    Biochem J; 2015 Dec; 472(2):e25-6. PubMed ID: 26567273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional significance of O-GlcNAc modification in regulating neuronal properties.
    Hwang H; Rhim H
    Pharmacol Res; 2018 Mar; 129():295-307. PubMed ID: 29223644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Conserved Splicing Silencer Dynamically Regulates O-GlcNAc Transferase Intron Retention and O-GlcNAc Homeostasis.
    Park SK; Zhou X; Pendleton KE; Hunter OV; Kohler JJ; O'Donnell KA; Conrad NK
    Cell Rep; 2017 Aug; 20(5):1088-1099. PubMed ID: 28768194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.